Results 141 to 150 of about 8,121 (227)

Treatments and Targets to Achieve Disease Control in Chronic Spontaneous Urticaria: Current and Emerging Therapeutic Options. [PDF]

J Inflamm Res
Østergaard CES, Thomsen SF, Zhang DG.
europepmc   +1 more source

Wake-promoting neuromodulators in Alzheimer's disease: Implications for sleep and brain clearance. [PDF]

Alzheimers Dement
Pedersen TJ, Clemens SG, Winer JR, Sharma A, Falgàs N, Lucey BP, Gordon BA, Musiek ES.   +7 more
europepmc   +1 more source

Advances in the Management of Mediator-Related Symptoms in Non-Advanced Systemic Mastocytosis. [PDF]

Immunotargets Ther
Gülen T, Sabato V.
europepmc   +1 more source

Unravelling the Intricate Link: Mast Cells and Estrogen-Induced Pain Sensitization in Endometriosis. [PDF]

Int J Biol Sci
Wang J, Mao X, Zhu L, Zhang X.
europepmc   +1 more source

Irritable Bowel Syndrome Clinical Care Gaps and the Potential of Future Therapeutics Based on Peripheral Visceral Afferent Modulation. [PDF]

Clin Gastroenterol Hepatol
Camilleri M.
europepmc   +1 more source

Neurotransmitter Systems in Alzheimer's Disease. [PDF]

Curr Issues Mol Biol
Ramírez-Expósito MJ, Cueto-Ureña C, Martínez-Martos JM.   +2 more
europepmc   +1 more source

TRPV4-Mast Cell Interactions in Neurogenic Inflammation and Chronic Diseases: A Narrative Review. [PDF]

Int J Mol Sci
Fouani M, Kumari S, Charles A, Wickware C, Moore AA, Cho CH, Abraham SN, Moore CD.   +7 more
europepmc   +1 more source

Molecular docking analysis of phytoconstituents from <i>Nilavaagai Chooranam</i> with histamine H1 receptor. [PDF]

Bioinformation
Balasubramaniam VB, Ramamoorthy V, Balasubramanian S, Annamalai S, Ravichandran D.   +4 more
europepmc   +1 more source

MRGPRX2 as a novel therapeutic target in headache. [PDF]

Neurotherapeutics
Nematgorgani S, Brandon JM, Dussor G.
europepmc   +1 more source